IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0012747.html
   My bibliography  Save this article

Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India

Author

Listed:
  • Lauren M Uhler
  • Nagalingeswaran Kumarasamy
  • Kenneth H Mayer
  • Anjali Saxena
  • Elena Losina
  • Malaisamy Muniyandi
  • Adam W Stoler
  • Zhigang Lu
  • Rochelle P Walensky
  • Timothy P Flanigan
  • Melissa A Bender
  • Kenneth A Freedberg
  • Soumya Swaminathan
  • for the CEPAC International investigators

Abstract

Background: Indian guidelines recommend routine referral for HIV testing of all tuberculosis (TB) patients in the nine states with the highest HIV prevalence, and selective referral for testing elsewhere. We assessed the clinical impact and cost-effectiveness of alternative HIV testing referral strategies among TB patients in India. Methods and Findings: We utilized a computer model of HIV and TB disease to project outcomes for patients with active TB in India. We compared life expectancy, cost, and cost-effectiveness for three HIV testing referral strategies: 1) selective referral for HIV testing of those with increased HIV risk, 2) routine referral of patients in the nine highest HIV prevalence states with selective referral elsewhere (current standard), and 3) routine referral of all patients for HIV testing. TB-related data were from the World Health Organization. HIV prevalence among TB patients was 9.0% in the highest prevalence states, 2.9% in the other states, and 4.9% overall. The selective referral strategy, beginning from age 33.50 years, had a projected discounted life expectancy of 16.88 years and a mean lifetime HIV/TB treatment cost of US$100. The current standard increased mean life expectancy to 16.90 years with additional per-person cost of US$10; the incremental cost-effectiveness ratio was US$650/year of life saved (YLS) compared to selective referral. Routine referral of all patients for HIV testing increased life expectancy to 16.91 years, with an incremental cost-effectiveness ratio of US$730/YLS compared to the current standard. For HIV-infected patients cured of TB, receiving antiretroviral therapy increased survival from 4.71 to 13.87 years. Results were most sensitive to the HIV prevalence and the cost of second-line antiretroviral therapy. Conclusions: Referral of all patients with active TB in India for HIV testing will be both effective and cost-effective. While effective implementation of this strategy would require investment, routine, voluntary HIV testing of TB patients in India should be recommended.

Suggested Citation

  • Lauren M Uhler & Nagalingeswaran Kumarasamy & Kenneth H Mayer & Anjali Saxena & Elena Losina & Malaisamy Muniyandi & Adam W Stoler & Zhigang Lu & Rochelle P Walensky & Timothy P Flanigan & Melissa A B, 2010. "Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India," PLOS ONE, Public Library of Science, vol. 5(9), pages 1-9, September.
    • Handle: RePEc:plo:pone00:0012747
    DOI: 10.1371/journal.pone.0012747
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012747
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0012747&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0012747?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. S.J. Goldie & Y. Yazdanpanah & E. Losina & M.C. Weinstein & X. Anglaret & R.P. Walensky & H.E. Hsu & A. Kimmel & C. Holmes & J.E. Kaplan & K.A. Freedberg, 2006. "Cost-effectiveness of HIV treatment in Resource-Poor Settings - The case of Côte d'Ivoire," Post-Print hal-00199992, HAL.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kartik K Venkatesh & Jessica E Becker & Nagalingeswaran Kumarasamy & Yoriko M Nakamura & Kenneth H Mayer & Elena Losina & Soumya Swaminathan & Timothy P Flanigan & Rochelle P Walensky & Kenneth A Free, 2013. "Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-11, May.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ingrid V Bassett & Darshini Govindasamy & Alison S Erlwanger & Emily P Hyle & Katharina Kranzer & Nienke van Schaik & Farzad Noubary & A David Paltiel & Robin Wood & Rochelle P Walensky & Elena Losina, 2014. "Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-11, January.
    2. Damon, Maria & Zivin, Joshua Graff & Thirumurthy, Harsha, 2015. "Health shocks and natural resource management: Evidence from Western Kenya," Journal of Environmental Economics and Management, Elsevier, vol. 69(C), pages 36-52.
    3. Bärnighausen, Till & Bloom, David E., 2009. ""Conditional scholarships" for HIV/AIDS health workers: Educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa," Social Science & Medicine, Elsevier, vol. 68(3), pages 544-551, February.
    4. Romain Micol & Ayden Tajahmady & Olivier Lortholary & Suna Balkan & Catherine Quillet & Jean-Philippe Dousset & Hak Chanroeun & Yoann Madec & Arnaud Fontanet & Yazdan Yazdanpanah, 2010. "Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia," PLOS ONE, Public Library of Science, vol. 5(11), pages 1-8, November.
    5. April D. Kimmel & Daniel W. Fitzgerald & Jean W. Pape & Bruce R. Schackman, 2015. "Performance of a Mathematical Model to Forecast Lives Saved from HIV Treatment Expansion in Resource-Limited Settings," Medical Decision Making, , vol. 35(2), pages 230-242, February.
    6. James G Kahn & Nicholas Muraguri & Brian Harris & Eric Lugada & Thomas Clasen & Mark Grabowsky & Jonathan Mermin & Shahnaaz Shariff, 2012. "Integrated HIV Testing, Malaria, and Diarrhea Prevention Campaign in Kenya: Modeled Health Impact and Cost-Effectiveness," PLOS ONE, Public Library of Science, vol. 7(2), pages 1-9, February.
    7. Kartik K Venkatesh & Jessica E Becker & Nagalingeswaran Kumarasamy & Yoriko M Nakamura & Kenneth H Mayer & Elena Losina & Soumya Swaminathan & Timothy P Flanigan & Rochelle P Walensky & Kenneth A Free, 2013. "Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-11, May.
    8. Juan J. DelaCruz, 2018. "Foreign Aid and HIV/AIDS in Latin America and the Caribbean: Should We Adjust the Degree of Response?," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 46(3), pages 337-349, September.
    9. Nicolas A Menzies & Andres A Berruti & John M Blandford, 2012. "The Determinants of HIV Treatment Costs in Resource Limited Settings," PLOS ONE, Public Library of Science, vol. 7(11), pages 1-9, November.
    10. Yazdan Yazdanpanah & Julian Perelman & Madeline A DiLorenzo & Joana Alves & Henrique Barros & Céu Mateus & João Pereira & Kamal Mansinho & Marion Robine & Ji-Eun Park & Eric L Ross & Elena Losina & Ro, 2013. "Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness," PLOS ONE, Public Library of Science, vol. 8(12), pages 1-1, December.
    11. Elliot Marseille & Mark J Giganti & Albert Mwango & Angela Chisembele-Taylor & Lloyd Mulenga & Mead Over & James G Kahn & Jeffrey S A Stringer, 2012. "Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-13, December.
    12. David M. Eddy & William Hollingworth & J. Jaime Caro & Joel Tsevat & Kathryn M. McDonald & John B. Wong, 2012. "Model Transparency and Validation," Medical Decision Making, , vol. 32(5), pages 733-743, September.
    13. Muhammad Hamza & Maryam A Idris & Musa B Maiyaki & Mohammed Lamorde & Jean-Philippe Chippaux & David A Warrell & Andreas Kuznik & Abdulrazaq G Habib, 2016. "Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 10(3), pages 1-16, March.
    14. Taghreed Adam & David B Evans & Bian Ying & Christopher J L Murray, 2014. "Variability in Costs across Hospital Wards. A Study of Chinese Hospitals," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-8, May.
    15. Rachel M Smith & Tuan Anh Nguyen & Hoang Thi Thanh Ha & Pham Hong Thang & Cao Thuy & Truong Xuan Lien & Hien T Bui & Thai Hung Le & Bruce Struminger & Michelle S McConnell & Robyn Neblett Fanfair & Be, 2013. "Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam," PLOS ONE, Public Library of Science, vol. 8(4), pages 1-9, April.
    16. Abdulrazaq G Habib & Mohammed Lamorde & Mahmood M Dalhat & Zaiyad G Habib & Andreas Kuznik, 2015. "Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 9(1), pages 1-7, January.
    17. Dustin J. Rabideau & Pamela P. Pei & Rochelle P. Walensky & Amy Zheng & Robert A. Parker, 2018. "Implementing Generalized Additive Models to Estimate the Expected Value of Sample Information in a Microsimulation Model: Results of Three Case Studies," Medical Decision Making, , vol. 38(2), pages 189-199, February.
    18. Antonieta Medina Lara & Jesse Kigozi & Jovita Amurwon & Lazarus Muchabaiwa & Barbara Nyanzi Wakaholi & Ruben E Mujica Mota & A Sarah Walker & Ronnie Kasirye & Francis Ssali & Andrew Reid & Heiner Gros, 2012. "Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-10, April.
    19. Kjell Hausken & Mthuli Ncube, 2020. "Game theoretic analysis of persons, the pharmaceutical industry, and donors in disease contraction and recovery," Palgrave Communications, Palgrave Macmillan, vol. 7(1), pages 1-17, December.
    20. Joseph B Babigumira & Andy Stergachis & David L Veenstra & Jacqueline S Gardner & Joseph Ngonzi & Peter Mukasa-Kivunike & Louis P Garrison, 2012. "Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda," PLOS ONE, Public Library of Science, vol. 7(2), pages 1-9, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0012747. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.